Circulation research, 2021-05, Vol.128 (11), p.1616-1625
2021
Details
- Autor(en) / Beteiligte
- Titel
- Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis
- Ist Teil von
- Circulation research, 2021-05, Vol.128 (11), p.1616-1625
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2021
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- [Figure: see text].
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0009-7330eISSN: 1524-4571DOI: 10.1161/circresaha.120.318556Titel-ID: cdi_proquest_miscellaneous_2509610378
- Format
- –
- Schlagworte
- Death, Sudden, Cardiac - prevention & control, Disease Progression, Female, Fibroblast Growth Factor-23 - blood, Humans, Hydroxycholecalciferols - administration & dosage, Hydroxycholecalciferols - adverse effects, Hydroxycholecalciferols - therapeutic use, Hyperparathyroidism, Secondary - blood, Hyperparathyroidism, Secondary - etiology, Hypertrophy, Left Ventricular - blood, Hypertrophy, Left Ventricular - diagnostic imaging, Hypertrophy, Left Ventricular - drug therapy, Hypertrophy, Left Ventricular - etiology, Hypocalcemia - chemically induced, Intention to Treat Analysis, Klotho Proteins - blood, Magnetic Resonance Imaging, Male, Middle Aged, Parathyroid Hormone - blood, Peptides - administration & dosage, Peptides - adverse effects, Peptides - therapeutic use, Phosphates - blood, Renal Dialysis, Renal Insufficiency, Chronic - blood, Renal Insufficiency, Chronic - complications, Renal Insufficiency, Chronic - therapy, Single-Blind Method